Undiagnosed RA During the Pandemic The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests. https://t.co/qEcEF8ukxm https://t.co/PcXAxrjT24

• https://bit.ly/3E7zEWY

Full read review of advances in bone biology leading to drug development (denosumab, romosuzumab, Burosumab), advances in Pagets and rickets and key regulatory molecules for bone remodeling, RANK, RANKL, OPG, & sclerostin https://t.co/CMMzIrZRUa https://t.co/ABhaHxP8y2

• https://bit.ly/3UysPDA

Dr. Patricia Harkins, @DrTrishHarkins, is new to the #ACR22 RheumNow reporter team. From Dr. Harkins, "I am really looking forward to the new "Ignite sessions", as well as working with the Rheum Now Faculty for the first time!" Follow her for real-time #ACR22 coverage! https://t.co/dpDfNJs1V4

"I can't wait to see how the new format works: the poster hall, the SPARK talks, and to see a whole lot of people in person!" Follow Dr. David Liew, @drdavidliew, for real-time #ACR22 coverage! https://t.co/RBbLyqrBNT

Drug-induced Hepatotoxicity - many Rheum drugs on the list: Tylenol, azathioprine, allopurinol, cyclosporine, dapsone, gold, MTX, 6-MP, NSAIDs, ASA, SSZ, Minocin... https://t.co/tAaW41h7xS https://t.co/fn8sNbeslH

• https://bit.ly/3hbDCFl

From the Crypt: Rheumatology Dead Word Cemetery Arthritis, Rheumatic Disease and Rheumatology cover a catalogue of ageless disorders w/decades, if not centuries, of history behind them.Enjoy our blog on retired Rheum sayings, as so decreed by RheumNow. https://t.co/WyBFEVa1h5 https://t.co/eE3HQ4N5Ia

• https://bit.ly/3T1uyQl

2022 New Drug Approvals Download today! https://t.co/nz91Ckw0AZ https://t.co/QieTvcqjcy

• https://bit.ly/3zL05iH

One week away! #ACR22 https://t.co/bvFCfFpQom

“I am looking forward to the ACR to hear about the ground-breaking results from basic science to the new treatments. I am delighted to be part of the RheumNow faculty covering the many topics from #ACR22. “ Follow Dr. Chan at @synovialjoints for real-time coverage of #ACR22. https://t.co/i6OZRHlBaE

New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes? This and more on the latest RheumNow podcast. https://t.co/4YBqHjI3VL https://t.co/g2pE72pyEk

• https://bit.ly/3WxS9LK

“At the ACR I am looking forward to meeting colleagues in person, having some great food in Philadelphia and to learning alot as a RheumNow reporter!” Dr. Janet Pope is back for #ACR22 as a RheumNow reporter, sharing real-time coverage on many topics. Follow her @Janetbirdope https://t.co/ROD7oan4KZ

SLE T2T - Lupus Low Disease Activity State Predicts Outcomes A prospective study shows that T2T with a goal of LLDAS and remission has been shown to improve mortality risk. https://t.co/WRaqjdVi9G https://t.co/3guKt0Qby9

• https://bit.ly/3DA4lTw

2022 CDC Clinical Practice Guideline on Opioid Prescribing The CDC has updated its Guideline for Prescribing Opioids for Chronic Pain and includes recommendations for managing acute, subacute, and chronic pain. https://t.co/aFE4fUpIWn https://t.co/kG8QlVy2bG

• https://bit.ly/3UmTQcL

Population study shows among vaccinated gout pts, COVID breakthrough infection occurred in @ 4.68/1K Pt-mos vs 3.76/1K Pt-mos in non-Gout persons. Gout w/ Covid had More Hosp (aHR=1.30) & death (aHR=1.36), moreso in Women w/ gout (aHR 1.55 & 2.46) https://t.co/ViwiPzqTbZ https://t.co/BrXd6pbgRI

• https://bit.ly/3gYUcYI